Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor.
Nat Med. 2022 Oct;28(10):2171-2182. doi: 10.1038/s41591-022-02007-7. Epub 2022 Oct 10.
Nat Med. 2022.
PMID: 36216931